Begin main content

Reports

We found 5986 result(s)

2019 CADTH Symposium

Event Date: April 14, 2019 - April 16, 2019
Result type: Events

CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to symposium@cadth.ca.

rivaroxaban (Xarelto)

Last Updated: November 13, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: rivaroxaban
Indications: Prevention of stroke and cardiovascular events in coronary and peripheral artery disease.

  • Brand Name: Xarelto
  • Manufacturer: Bayer Inc.
  • Project Number: SR0569-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Coronary Artery Disease, Stroke, Cardiovascular, Coronary artery disease, Heart attack, Peripheral vascular disease, Stroke

risankizumab (TBC)

Last Updated: November 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: risankizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: TBC
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0583-000
  • Project Status: Active
  • Submission Type: New

Tags

Dermatology, Dermatology

sucroferric oxyhydroxide (Velphoro )

Last Updated: November 9, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: sucroferric oxyhydroxide
Indications: Hyperphosphatemia, end-stage renal disease

  • Brand Name: Velphoro
  • Manufacturer: Vifor Fresenius Medical Care Renal Pharma
  • Project Number: SR0571-000
  • Project Status: Active
  • Submission Type: New

Tags

Kidney

Nusinersen (Spinraza)

Last Updated: November 9, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0576-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Genetics, Nervous System, Pediatrics, Genetics, Musculoskeletal, Nervous system, Pediatrics

tofacitinib (Xeljanz)

Last Updated: November 9, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: tofacitinib
Indications: Ulcerative colitis

  • Brand Name: Xeljanz
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SR0572-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Digestive System, Gastrointestinal Tract, Digestive system, Gastrointestinal tract

filgrastim (TBC)

Last Updated: November 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: filgrastim
Indications: Prevention or treatment of neutropenia in various indications

  • Brand Name: TBC
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: SE0585-000
  • Project Status: Active
  • Submission Type: New

Tags

Blood, Cancer, Pediatrics, Blood, Cancer, HIV/AIDS, Pediatrics

edaravone (Radicava)

Last Updated: November 9, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: edaravone
Indications: amyotrophic lateral sclerosis

  • Brand Name: Radicava
  • Manufacturer: Mitsubishi Tanabe Pharma Corporation
  • Project Number: SR0573-000
  • Project Status: Active
  • Submission Type: New

Tags

Nervous System, Nervous system

Flash Glucose Monitoring Systems for Adults with Type 1 or Type 2 Diabetes

Last Updated: November 12, 2018
Result type: Projects in Progress
Report Type: Health Technology Assessment

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...

Foot Drop Stimulators for Foot Drop: A Review of Clinical, Cost-Effectiveness and Guidelines

Last Updated: November 12, 2018
Result type: Projects in Progress
Report Type: Summary with Critical Appraisal

This is a new CADTH project. Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies. The Projects in Progress page on the CADTH website is updated on a seven to eight-day cycle. View other current Projects...